Dextrorotatory opioids induce stereotyped behavior in Sprague-Dawley and Dark Agouti rats

J. E. Ishmael, P. H. Franklin, Thomas F. Murray

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Dextromethorphan and dextrorphan elicited a stereotyped behavioral syndrome in rats indistinguishable from that produced by PCP and other non- competitive NMDA antagonists. The rank order of potency for the induction of stereotyped behavior in male Sprague-Dawley rats was: MK- 801>PCP>(±)cyclazocine>dextrorphan>(±)ketamine>dextromethorphan. These behavioral potencies were significantly correlated (0.91; P3H]dextrorphan-labelled NMDA receptors in rat forebrain membranes. To address the propensity of dextromethorphan to induce stereotyped behavior, dextrorotatory-opioid induced stereotypies were investigated in female Dark Agouti and female Sprague-Dawley rats. The female Dark Agouti lacks CYP2D1, the cytochrome P450 enzyme which catalyses the oxidative O-demethylation of dextromethorphan to dextrorphan. No differences were observed in either potency or time to peak effect for dextromethorphan to induce stereotyped behavior in the rat strains, suggesting that the affinity of dextromethorphan for NMDA receptors adequately accounts for its ability to induce stereotyped behavior. Female Dark Agouti rats were, however, more sensitive to the effects of dextrorphan, which may reflect differences in the ability of this strain to metabolize dextrorphan. We find no evidence to suggest that dextromethorphan produces a behavioral syndrome in rats that is distinct from that induced by dextrorphan. The commonality between the pharmacologic profiles of these compounds suggests that the abuse potential of dextromethorphan containing antitussive preparations is related to the non-competitive NMDA antagonist activity of dextromethorphan and its metabolites.

Original languageEnglish
Pages (from-to)206-216
Number of pages11
JournalPsychopharmacology
Volume140
Issue number2
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Dextromethorphan
Stereotyped Behavior
Dextrorphan
Opioid Analgesics
Aptitude
N-Methylaspartate
N-Methyl-D-Aspartate Receptors
Cytochrome P-450 Enzyme System
Sprague Dawley Rats
Cyclazocine
Antitussive Agents
Dasyproctidae
Dizocilpine Maleate
Ketamine
Prosencephalon

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Dextrorotatory opioids induce stereotyped behavior in Sprague-Dawley and Dark Agouti rats. / Ishmael, J. E.; Franklin, P. H.; Murray, Thomas F.

In: Psychopharmacology, Vol. 140, No. 2, 1998, p. 206-216.

Research output: Contribution to journalArticle

@article{658af7c402c9468aaf5ae980d492ce35,
title = "Dextrorotatory opioids induce stereotyped behavior in Sprague-Dawley and Dark Agouti rats",
abstract = "Dextromethorphan and dextrorphan elicited a stereotyped behavioral syndrome in rats indistinguishable from that produced by PCP and other non- competitive NMDA antagonists. The rank order of potency for the induction of stereotyped behavior in male Sprague-Dawley rats was: MK- 801>PCP>(±)cyclazocine>dextrorphan>(±)ketamine>dextromethorphan. These behavioral potencies were significantly correlated (0.91; P3H]dextrorphan-labelled NMDA receptors in rat forebrain membranes. To address the propensity of dextromethorphan to induce stereotyped behavior, dextrorotatory-opioid induced stereotypies were investigated in female Dark Agouti and female Sprague-Dawley rats. The female Dark Agouti lacks CYP2D1, the cytochrome P450 enzyme which catalyses the oxidative O-demethylation of dextromethorphan to dextrorphan. No differences were observed in either potency or time to peak effect for dextromethorphan to induce stereotyped behavior in the rat strains, suggesting that the affinity of dextromethorphan for NMDA receptors adequately accounts for its ability to induce stereotyped behavior. Female Dark Agouti rats were, however, more sensitive to the effects of dextrorphan, which may reflect differences in the ability of this strain to metabolize dextrorphan. We find no evidence to suggest that dextromethorphan produces a behavioral syndrome in rats that is distinct from that induced by dextrorphan. The commonality between the pharmacologic profiles of these compounds suggests that the abuse potential of dextromethorphan containing antitussive preparations is related to the non-competitive NMDA antagonist activity of dextromethorphan and its metabolites.",
author = "Ishmael, {J. E.} and Franklin, {P. H.} and Murray, {Thomas F.}",
year = "1998",
doi = "10.1007/s002130050759",
language = "English",
volume = "140",
pages = "206--216",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Dextrorotatory opioids induce stereotyped behavior in Sprague-Dawley and Dark Agouti rats

AU - Ishmael, J. E.

AU - Franklin, P. H.

AU - Murray, Thomas F.

PY - 1998

Y1 - 1998

N2 - Dextromethorphan and dextrorphan elicited a stereotyped behavioral syndrome in rats indistinguishable from that produced by PCP and other non- competitive NMDA antagonists. The rank order of potency for the induction of stereotyped behavior in male Sprague-Dawley rats was: MK- 801>PCP>(±)cyclazocine>dextrorphan>(±)ketamine>dextromethorphan. These behavioral potencies were significantly correlated (0.91; P3H]dextrorphan-labelled NMDA receptors in rat forebrain membranes. To address the propensity of dextromethorphan to induce stereotyped behavior, dextrorotatory-opioid induced stereotypies were investigated in female Dark Agouti and female Sprague-Dawley rats. The female Dark Agouti lacks CYP2D1, the cytochrome P450 enzyme which catalyses the oxidative O-demethylation of dextromethorphan to dextrorphan. No differences were observed in either potency or time to peak effect for dextromethorphan to induce stereotyped behavior in the rat strains, suggesting that the affinity of dextromethorphan for NMDA receptors adequately accounts for its ability to induce stereotyped behavior. Female Dark Agouti rats were, however, more sensitive to the effects of dextrorphan, which may reflect differences in the ability of this strain to metabolize dextrorphan. We find no evidence to suggest that dextromethorphan produces a behavioral syndrome in rats that is distinct from that induced by dextrorphan. The commonality between the pharmacologic profiles of these compounds suggests that the abuse potential of dextromethorphan containing antitussive preparations is related to the non-competitive NMDA antagonist activity of dextromethorphan and its metabolites.

AB - Dextromethorphan and dextrorphan elicited a stereotyped behavioral syndrome in rats indistinguishable from that produced by PCP and other non- competitive NMDA antagonists. The rank order of potency for the induction of stereotyped behavior in male Sprague-Dawley rats was: MK- 801>PCP>(±)cyclazocine>dextrorphan>(±)ketamine>dextromethorphan. These behavioral potencies were significantly correlated (0.91; P3H]dextrorphan-labelled NMDA receptors in rat forebrain membranes. To address the propensity of dextromethorphan to induce stereotyped behavior, dextrorotatory-opioid induced stereotypies were investigated in female Dark Agouti and female Sprague-Dawley rats. The female Dark Agouti lacks CYP2D1, the cytochrome P450 enzyme which catalyses the oxidative O-demethylation of dextromethorphan to dextrorphan. No differences were observed in either potency or time to peak effect for dextromethorphan to induce stereotyped behavior in the rat strains, suggesting that the affinity of dextromethorphan for NMDA receptors adequately accounts for its ability to induce stereotyped behavior. Female Dark Agouti rats were, however, more sensitive to the effects of dextrorphan, which may reflect differences in the ability of this strain to metabolize dextrorphan. We find no evidence to suggest that dextromethorphan produces a behavioral syndrome in rats that is distinct from that induced by dextrorphan. The commonality between the pharmacologic profiles of these compounds suggests that the abuse potential of dextromethorphan containing antitussive preparations is related to the non-competitive NMDA antagonist activity of dextromethorphan and its metabolites.

UR - http://www.scopus.com/inward/record.url?scp=0031733726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031733726&partnerID=8YFLogxK

U2 - 10.1007/s002130050759

DO - 10.1007/s002130050759

M3 - Article

VL - 140

SP - 206

EP - 216

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 2

ER -